LeonaBio (LONA) Interest Expenses (2019 - 2026)
LeonaBio's (LONA) quarterly Interest Expenses came in at $3.9 million in Q1 2026, up 217.36% year-on-year from $1.2 million in Q1 2025, and up 91.82% on a QoQ basis from $2.0 million in Q4 2025.
LeonaBio (LONA) Interest Expenses (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Interest Expenses data on file, last reported at $3.9 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 217.36% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $3.9 million, a 217.36% increase from a year earlier, with the FY2025 full-year figure at $112.6 million, up 22.48% from the prior year.
- Interest Expenses for Q1 2026 stood at $3.9 million, up from $2.0 million in the prior quarter.
- Over the last five years, Interest Expenses for LONA reached as high as $91.9 million in Q4 2024 and fell as low as $387000.0 in Q4 2023.
- Historically, Interest Expenses has averaged $7.4 million across 5 years, with a median of $1.7 million in 2024.
- Across the five-year window, Interest Expenses jumped 39700.0% in 2022 and tumbled 97.79% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $396000.0 in 2022, then dropped by 2.27% to $387000.0 in 2023, then surged by 23659.43% to $91.9 million in 2024, then tumbled by 97.79% to $2.0 million in 2025, then jumped by 91.82% to $3.9 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $3.9 million in Q1 2026, $2.0 million in Q4 2025, and $981000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.17 Bn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | 3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.89 Mn |
| Mar 31, 2026 | 3.89 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 981,000.00 |
| Sep 30, 2025 | 981,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 91.95 Mn |
| Dec 31, 2024 | 91.95 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 655,000.00 |
| Jun 30, 2024 | 655,000.00 |
| Mar 31, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 387,000.00 |
| Dec 31, 2023 | 387,000.00 |